The U.S. Government has agreed to pay Pfizer nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment, with the delivery of the remaining 20 million courses previously purchased planned for early 2023.
According to a report from CBS, Pfizer is expected to top $100 billion dollars in revenue, with more than half of it to come the COVID vaccines.
The report goes onto say that before the new contract, analysts forecasted Paxlovid sales would exceed 22 billion this year, and be close to 12 billion in 2023.
Just for your information, Ivermectin and hydroxychloroquine cost $1 per treatment course. Paxlovid™ costs $530…
Joe Biden will print $2 billion for Pfizer’s Paxlovid™.
Ivermectin and hydroxychloroquine cost $1 per treatment course.
Paxlovid™ costs $530.https://t.co/wR7ihEmN4P
— Marc Mongrain (@Lukathor) December 14, 2022
Pfizer last week announced a $750 million dollar investment in the facility in Kalamazoo County, which will result in hundreds of new jobs in and around Portage.
The Portage MI facility made the first COVID-19 vaccine two years ago, and is expected to announce it will invest millions for the production of Paxlovid in June 2023. [WHTC]